Share on StockTwits

Stock Analysts’ ratings reiterations for Tuesday, June 3rd:

Ambev SA (NASDAQ:ABEV) had its overweight rating reaffirmed by analysts at JPMorgan Chase & Co.. They currently have a $8.10 target price on the stock, up from their previous target price of $7.90.

Aetna (NYSE:AET) had its overweight rating reaffirmed by analysts at JPMorgan Chase & Co.. The firm currently has a $81.00 price target on the stock, up from their previous price target of $78.00.

Big 5 Sporting Goods (NASDAQ:BGFV) had its underperform rating reiterated by analysts at Zacks. Zacks currently has a $11.00 price target on the stock. Zacks’ analyst wrote, “The near-term prospects of Big 5 Sporting seem gloomy, given its projections for a challenging second-quarter 2014, which will be characterized by a continued decline in the demand for firearms and ammunition products and a soft consumer environment. As a result, the company formulated a disappointing second-quarter guidance that projects a low negative to low positive single-digit comps growth along with earnings in the range of $0.12 to $0.20. This compares to comps growth of 4.4% and earnings of $0.28 per share in the second quarter of 2013. Moreover, the entry of DICK’s Sporting’s into smaller and mid-sized markets and Sports Chalet and Sports Authority’s venture into the small store format may take a toll on the company’s performance. Taking cue from the troubles ahead, we have downgraded Big 5 to Underperform.”

The Bank of New York Mellon (NYSE:BK) had its neutral rating reissued by analysts at Zacks. Zacks currently has a $36.00 price target on the stock. Zacks’ analyst wrote, “BNY Mellon’s first-quarter 2014 earnings outpaced the Zacks Consensus Estimate. Results benefited from an increase in net interest revenues and fee income as well as prudent expense management partially offset by lower benefit from provisions. Additionally, consistent improvements in asset position as well as strong capital ratios were the tailwinds. We expect the top line to continue benefiting from various restructuring initiatives and acquisitions going forward. Moreover, a strong capital position and enhanced capital deployment activities will continue to boost investors’ confidence. However, a still low interest rate environment, slow economic recovery and changing regulations are expected to dent the company’s performance in the near term.”

Broadcom (NASDAQ:BRCM) had its outperform rating reaffirmed by analysts at FBR Capital Markets. The firm currently has a $39.00 price target on the stock, up from their previous price target of $35.00.

Compania Cervecerias Unidas (NYSE:CCU) had its neutral rating reissued by analysts at JPMorgan Chase & Co.. JPMorgan Chase & Co. currently has a $25.00 price target on the stock, up from their previous price target of $22.00.

CIGNA (NYSE:CI) had its overweight rating reaffirmed by analysts at JPMorgan Chase & Co.. JPMorgan Chase & Co. currently has a $95.00 target price on the stock, down from their previous target price of $96.00.

Comerica (NYSE:CMA) had its neutral rating reissued by analysts at Zacks. The firm currently has a $51.00 target price on the stock. Zacks’ analyst wrote, “Comerica continued the trend of impressive operating earnings as it outpaced the Zacks Consensus Estimate in first-quarter 2014. Also, it came above the prior-year quarter earnings as well. Results reflected declining expenses and lower provision for credit losses, partially offset by decline in top line. Further, announcement of capital deployment activities following the Fed’s approval of 2014 capital plan enhanced investors’ confidence in the stock. Going forward, we believe that continuous geographic diversification beyond the company’s traditional and slower-growing Midwest markets could drive growth over the coming quarters. However, an unsettled economic environment, regulatory overhangs and pressure on net interest margin continue to be our concerns. “

Chartwell Retirement Residences (TSE:CSH.UN) had its outperform rating reaffirmed by analysts at Scotiabank. Scotiabank currently has a C$11.50 target price on the stock.

Community Health Systems (NYSE:CYH) had its overweight rating reissued by analysts at JPMorgan Chase & Co.. They currently have a $47.00 target price on the stock, up from their previous target price of $46.00.

Detour Gold (TSE:DGC) had its focus stock rating reiterated by analysts at Scotiabank. Scotiabank currently has a C$17.00 price target on the stock.

DelMar Pharmaceuticals (NASDAQ:DMPI) had its outperform rating reissued by analysts at Zacks. Zacks currently has a $4.50 target price on the stock. Zacks’ analyst wrote, “DMPI is a clinical/commercial stage drug development company with a focus on oncology. We are impressed with the efficacy data and safety profile of its lead drug candidate VAL-083 for brain cancer. DMPI recently reported positive VAL-083 Phase I/II clinical data for brain cancer. The company is on track to initiate registration directed trial of VAL-083 for brain cancer in2H 2014. Valuation is attractive now. We maintain an Outperform rating on its shares. “

El Paso Pipeline Partners, L.P. (NYSE:EPB) had its hold rating reiterated by analysts at Jefferies Group. The firm currently has a $32.00 price target on the stock, up from their previous price target of $31.00.

HCA Holdings (NYSE:HCA) had its overweight rating reissued by analysts at JPMorgan Chase & Co.. JPMorgan Chase & Co. currently has a $60.00 price target on the stock, up from their previous price target of $58.00.

Health Net (NYSE:HNT) had its neutral rating reaffirmed by analysts at JPMorgan Chase & Co.. The firm currently has a $40.00 price target on the stock, up from their previous price target of $38.00.

Coca-Cola FEMSA, S.A.B. de C.V. (NYSE:KOF) had its neutral rating reissued by analysts at JPMorgan Chase & Co.. They currently have a $140.00 target price on the stock, up from their previous target price of $105.00.

LifePoint Hospitals (NASDAQ:LPNT) had its overweight rating reaffirmed by analysts at JPMorgan Chase & Co.. JPMorgan Chase & Co. currently has a $65.00 price target on the stock, up from their previous price target of $62.00.

Pall Corp. (NYSE:PLL) had its neutral rating reissued by analysts at JPMorgan Chase & Co.. They currently have a $83.00 target price on the stock, up from their previous target price of $80.00.

Tenet Healthcare Corp (NYSE:THC) had its overweight rating reaffirmed by analysts at JPMorgan Chase & Co.. They currently have a $57.00 price target on the stock, up from their previous price target of $52.00.

Universal Health Services (NYSE:UHS) had its overweight rating reaffirmed by analysts at JPMorgan Chase & Co.. JPMorgan Chase & Co. currently has a $97.00 price target on the stock, up from their previous price target of $90.00.

WellPoint (NYSE:WLP) had its neutral rating reiterated by analysts at JPMorgan Chase & Co.. The firm currently has a $114.00 price target on the stock, up from their previous price target of $109.00.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.